Skip to main content
. 2024 Nov 11;17:4993–5000. doi: 10.2147/IDR.S491615

Table 1.

The Laboratory Indexes of the Patient on Admission

Index, Unit Value Index, Unit Value
WBC, ×109/L 6.24 GLO, g/L 48.9↑
Neut, % 69.9 ALB, g/L 33.6
Lym, ×109/L 1.39 TBIL, μmol/L 24.8
RBC, ×1012/L 4.02↓ DBIL, μmol/L 13.2
HGB, g/L 110.0↓ PT, s 15.8↑
CRP, mg/L 10.4↑ PTA, % 69.0↓
ESR, mm/h 53↑ INR 1.29↑
HbA1c, % 6.1↑ D-D dimer, µg/mL FEU 0.34
Glu, mmol/L 13.8↑ G test, pg/mL 134.13
ALT, U/L 22 GM test 0.12
AST, U/L 42↑ / /

Notes: The normal reference range: White blood cell count (WBC): (3.50–9.50)×109/L; The percentage of Neutrophils (Neut%): 40.0%~75.0%; Lymphocyte (Lym): (1.10–3.20)×109/L; Red blood cell (RBC): (4.30–5.80)×1012/L; Hemoglobin (HGB): 130.0–175.0 g/L; C-reactive protein (CRP): >10 mg/L Suggest possible infection or inflammation; Erythrocyte sedimentation rate (ESR): (0.00–15.00) mm/h; Glycosylated hemoglobin (HbA1c): 4.0%-6.0%; Blood glucose (Glu): (4.4–6.1)mmol/L; Alanine aminotransferase (ALT): (0–41)U/L; Alanine aminotransferase (AST): (0–40)U/L; Globulin (GLO): (20–35) g/L; Albumin (ALB): (35–52)g/L; Total Bilirubin (TBIL): (0–26)μmol/L; Direct Bilirubin (DBIL): (0–8.0)μmol/L; Prothrombin time (PT): 11.5 s-14.5 s; Prothrombin activity (PTA): 75.0%-125.0%; International normalized ratio (INR): 0.80–1.20; D-D dimer: <0.5 µg/mL FEU; Serum (1,3)-β-D glucan test (G test): <70 pg/mL negative, 70–95 pg/mL uncertain, >95 pg/mL positive; Galactomannan test (GM test): <0.5 negative, ≥0.5 positive. ↑: Above the normal reference range. ↓: Below the normal reference range.